- Independent hospital
Preventx Limited Also known as Preventx Limited
Assessment report published 26 October 2026
Contents
Judgements
Our view of the service
We carried out an unannounced inspection of the pathology service on 4 August 2026. This was the first inspection of the provider. The location was not rated because CQC does not rate pathological laboratories.
Preventx provided digital sexual health and laboratory services across England. People accessed services through online assessments and home-sampling kits. This helped people access testing, advice and HIV prevention services more easily.
The provider continued to develop digital Pre-Exposure Prophylaxis (PrEP) services. PrEP is a medicine that helps prevent HIV in people at risk of acquiring the virus. This service provided an alternative to attending a clinic and helped improve access to HIV prevention.
The laboratory processes more than 4 million tests each year from around 1.8 million samples. Laboratory and operational teams worked together to manage the testing process from kit dispatch through to reporting results.
The provider used quality checks, testing procedures and external reviews to help ensure results were accurate and reliable. Clinical oversight, safeguarding processes and laboratory controls helped keep people safe.
Although the service mainly provided testing and screening, some people also received clinical assessment, safeguarding review and follow-up support. Test results informed treatment decisions, referrals and access to ongoing care when needed.
Staff described a positive culture and spoke positively about leaders. They said leaders were visible, supportive and approachable. Leaders used feedback from staff, service users and stakeholders to improve services.
Leaders understood the main challenges facing the service. These included recruitment records, staffing pressures in some laboratory roles and laboratory failover arrangements. Work was underway to strengthen these areas and support the future development of the service.